Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Stopping isoniazid can reverse hair loss caused by the drug.

Drospirenone can hide symptoms of certain hormonal disorders, complicating diagnosis.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Diphencyprone therapy for hair loss can cause vitiligo.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

New compounds may help treat prostate issues without affecting androgen receptors.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Botanical extracts and Minoxidil improved hair condition in a boy with a genetic disorder.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.